Nuvation Bio (NUVB) Inventory (2025 - 2026)
Nuvation Bio (NUVB) posted quarterly Inventory of $15.8 million for Q1 2026, up 113071.43% year-over-year from N/an in Q1 2025, and up 38.85% quarter-over-quarter from $11.4 million in Q4 2025.
Powered by 
Analysis
Nuvation Bio (NUVB) Inventory (2025 - 2026) Analysis & Trends
Nuvation Bio (NUVB) has reported Inventory for 2 consecutive years, with $15.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory rose 113071.43% year-over-year to $15.8 million; the TTM figure through Mar 2026 stood at $15.8 million (up 113071.43% YoY), while the FY2025 annual figure was $11.4 million, changed N/A from the prior year.
- Inventory rose to $15.8 million in Q1 2026 per NUVB's latest filing, from $11.4 million in the prior quarter.
- Across five years, Inventory topped out at $15.8 million in Q1 2026 and bottomed at $14000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 280.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 732.60 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Nuvation Bio | 2.38 Bn | 2.38 Bn | 30.78 Mn | 19.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.90 Mn |
| Mar 31, 2026 | 15.84 Mn |
| Dec 31, 2025 | 11.41 Mn |
| Sep 30, 2025 | 5.71 Mn |
| Jun 30, 2025 | 552,000.00 |
| Mar 31, 2025 | 14,000.00 |